Sanofi to work with Curie on ovarian cancer targets

06/20/2013 | GenomeWeb Daily News (free registration)

Sanofi and the Curie Institute have agreed to cooperate in the search for new therapeutic targets for ovarian cancer using next-generation sequencing, reverse-phase protein analysis and patient-derived xenografts. The three-year collaboration seeks "to gain a better understanding of the molecular alterations that characterize many types of ovarian cancer, thereby enabling effective new drugs to be designed," the partners said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC